Audiometers in New York

Blaids LLC manufactures and sells direct-to-consumer professional-grade hearing aids featuring Wide Dynamic Range Compression (WDRC) technology and proprietary Digital Signal Processing algorithms. The company operates as an online hearing center offering fully programmable hearing aids across multiple form factors: the BlaidsX Neuro rechargeable Receiver-in-Canal (RIC) design starting at $499 per pair, the BlaidsX Pro Behind-the-Ear (BTE) model at $449 per pair, the BlaidsX Micro Invisible-in-Canal (ITC) at $899 per pair, and the InvisiHear Custom precision-manufactured device available in 48, 64, or 128 DSP channels from $1,299 per pair. All models incorporate AuralSense AI environmental sound optimization (included in units sold after September 2024). Devices feature professional-grade processing speeds (10MHz in Neuro models, 2.8ms latency), programmable settings across 250–8kHz frequency ranges, and are suitable for adults 18+ with mild to moderate hearing loss. The company positions itself as a direct-from-factory supplier eliminating traditional middlemen markups. Each purchase includes access to the Blaids Online Hearing Center with concierge audiology support, a 2-year warranty with $99 loss replacement coverage, free repairs, and a 45-day money-back guarantee. Customer ratings average 4.83 stars across 566 reviews. The company employs an in-house sound engineering team and maintains relationships with hospitals and clinics globally. Distribution extends to multiple currency zones (USD, CAD, EUR, GBP, JPY, INR, CNY, HKD, BRL, MXN).

Fortell Research Inc. is a hearing aid manufacturer and audiology clinic based in New York City. The company develops AI-enabled hearing aids that use spatial audio technology to isolate speech from background noise. Fortell's core offering is a direct-to-consumer hearing aid device paired with professional audiologist fitting and support services at their NYC clinic. The hearing aids employ real-time noise separation algorithms designed to address the "cocktail party problem"—the difficulty hearing speech in noisy environments. Clinical studies cited on their website report 10x improvement in word comprehension versus leading competitor AI hearing aids in background noise, up to 50x clearer speech via 17dB signal-to-noise ratio improvement, and 95% user preference over five top-specification competitors in controlled trials. The company offers a three-step fitting process: hearing evaluation, personalized demo programming, and fine-tuning for comfort and clarity. Currently operating a single clinic location in Manhattan at 530 Park Ave, Fortell indicates expansion plans to additional US cities. The company markets directly to consumers with hearing loss and positions itself as an alternative to traditional hearing aid retailers. No regulatory certifications (FDA 510(k), ISO 13485) are explicitly mentioned on the fetched site content. The clinical trial methodology is described as randomized controlled and overseen by outside academics, though specific regulatory pathway status is not disclosed.